Daniel R. Hart - Mar 14, 2023 Form 4 Insider Report for Avid Bioservices, Inc. (CDMO)

Role
Chief Financial Officer
Signature
/s/ Daniel R. Hart
Stock symbol
CDMO
Transactions as of
Mar 14, 2023
Transactions value $
-$83,680
Form type
4
Date filed
3/16/2023, 07:59 PM
Previous filing
Jan 11, 2023
Next filing
Apr 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Sale -$57K -3K -6.01% $19.00 47K Mar 14, 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Options Exercise $11.3K +2K +4.26% $5.66 49K Mar 14, 2023 Direct F1
transaction CDMO Common Stock, $0.001 par value Sale -$38K -2K -4.09% $19.00 47K Mar 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Stock Option(right to buy) Options Exercise $0 -2K -0.86% $0.00 230K Mar 14, 2023 Common Stock 2K $5.66 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 17, 2022.
F2 Stock option granted to the reporting person on August 1, 2018 vested in four (4) equal annual installments and was fully-vested as of August 1, 2022.